The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...

A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...

Abia State Agency for the Control of AIDS, ABSACA, has disclosed that 46,788 persons are currently undergoing treatment for ...

That needs to go much beyond this licensing that was already signed. We also have long-acting cabotegravir [a drug used for the treatment of HIV/AIDS], which … has been available for four years now.

If you take medications to treat HIV, some of those can also cause HIV rashes. Most HIV rashes aren't serious and will typically clear up in a few days to a few weeks, even without treatment.

It noted that it was “a pivotal step toward diminishing HIV/AIDS as a global health crisis”. The introduction of lenacapavir is potentially a major step forward in the treatment of HIV/AIDS ...

Approximately 1 million people are infected with HIV worldwide each year, and there is no cure. But many medications are available that can effectively control the virus once it has been diagnosed.

Gilead Sciences, GSK, ViiV Healthcare 1 to 3 years In June 2024, results from a trial of a new medicine to prevent HIV were announced—and they were jaw-dropping. Lenacapavir, a treatment ...

SOAR stepped in, hosting health fairs at which it distributed naloxone, an opioid overdose reversal drug; offered treatment and referrals; provided HIV testing; and exchanged clean syringes for ...

It was these insights that caught the attention of Gilead Sciences, prompting the company to search for drugs that target HIV's protein shell — otherwise known as a capsid — tapping Sundquist as a ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...